HDL and atherosclerosis: Insights from inherited HDL disorders

Laura Calabresi1, Monica Gomaraschi1, Sara Simonelli1

  • 1Centro Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano, Italy.

Insights

High-density lipoproteins (HDL) protect against cardiovascular disease by removing cholesterol. Inherited HDL disorders reveal how HDL subclasses impact this protective function.

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Genetics

Background:

  • Plasma high-density lipoproteins (HDL) are heterogeneous particles linked to atherosclerotic cardiovascular disease risk.
  • HDL's primary atheroprotective function is reverse cholesterol transport, removing cholesterol from macrophages.
  • HDLs also support endothelial homeostasis and possess antioxidant properties.

Purpose of the Study:

  • To investigate the functional differences among HDL subclasses.
  • To understand the relationship between HDL concentration, subclass distribution, and atheroprotection.
  • To leverage inherited HDL disorders as a model for studying HDL function.

Main Methods:

  • Analysis of HDL heterogeneity (density, size, composition).
  • Epidemiological correlation studies of HDL levels and cardiovascular disease.
  • Examination of rare monogenic HDL disorders with abnormal HDL subclass distribution.

Main Results:

  • HDL levels inversely correlate with atherosclerotic cardiovascular disease.
  • Individual HDL subclasses may possess distinct functional properties.
  • Inherited HDL disorders exhibit altered HDL subclass profiles and offer insights into HDL-mediated atheroprotection.

Conclusions:

  • Understanding HDL subclass function is crucial for defining the 'good' HDL particle.
  • Inherited HDL disorders provide a unique window into HDL's role in preventing cardiovascular disease.
  • Further research into HDL subclasses can refine strategies for cardiovascular risk reduction.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
719
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
925
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
68
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119